It has been suggested that estrogen modulates baroreflex regulation of autonomic function. The present study evaluated the effects of estrogen on baroreflex regulation of heart rate in response to changes in blood pressure with phenylephrine (PE), angiotensin II (AngII) and sodium nitroprusside (SNP) in a conscious mouse model. Males and ovariectomized females with (OvxE+) and without (OvxE-) estradiol replacement, chronically implanted with arterial and venous catheters were used in these studies. The slope of the baroreflex bradycardic responses to PE was significantly facilitated in OvxE+ females (-7.65±1.37) compared to OvxE-females (-4.5±0.4). Likewise, the slope of the baroreflex bradycardic responses to AngII was significantly facilitated in OvxE+ females (-7.97±1.06) compared to OvxE-females (-4.8±1.6). Reflex tachycardic responses to SNP were comparable in all the groups. Lastly, in male mice, the slope of AngII induced baroreflex bradycardia (-5.17±0.95) was significantly less than that induced by PE (-8.50±0.92), but this AngII mediated attenuation of reflex bradycardia was not observed in the female mice. These data support the hypothesis that estrogen facilitates baroreflex function in female mice and suggest that AngII mediated acute blunting of baroreflex regulation of heart rate may be sex dependent.
Introduction
Epidemiological studies have shown that cardiovascular diseases such as hypertension and coronary heart disease are less common in premenopausal women compared to age matched men (16, 18, 23, 50) . This innate protection in women against cardiovascular disease disappears with reproductive senescence or upon removal of endogenous ovarian steroids (4, 45, 49) .
It is thought that estrogen may affect cardiovascular function at numerous levels including the vasculature, heart and the brain (36, 46) . A potential mechanism by which estrogen provides cardioprotection in women is by acting at central cardiovascular regulatory centers to modulate autonomic regulation of the cardiovascular system.
Hormone replacement therapy appears to have favorable effects on the cardiovascular autonomic regulation in postmenopausal women by improving baroreflex sensitivity and over all heart rate variability (19) . Similar observations have also been made in male and ovariectomized female rats where estrogen replacement appears to improve baroreflex sensitivity via central mechanisms (32, 43) . However, to date, there have been no studies about the role of estrogen or gender in baroreflex control of heart rate in mice.
Angiotensin II (AngII) is a potent circulatory peptide implicated in pathogenesis of hypertension. In addition to its peripheral vasoconstrictor effects, this peptide has been known to modulate reflex regulation of heart rate and sympathetic activity through circumventricular organs such as the area postrema (13, 37) . In rabbits, dogs, and rats acute increases in circulating AngII blunts baroreflex regulation of heart rate (1, 31, 38, 39) .
It is interesting to know if centrally mediated effects of AngII on baroreflex function are affected by differences in circulating estrogen levels and gender.
The purpose of the present study was to investigate the effects of estrogen on baroreflex regulation of heart rate to increases in pressure with phenylephrine (PE) and angiotensin II (AngII) and decreases in pressure with sodium nitroprusside (SNP) in conscious freely moving ovariectomized female mice of C57/BL6J strain. In addition, these responses were compared to those of intact male mice. This strain of mouse is the most widely used background for studies on genetically modified animals. It was hypothesized that estrogen would facilitate the phenylephrine and AngII mediated baroreflex inhibition of heart rate in female ovariectomized mice.
METHODS

Animals
Male and female mice of C57/BL6J strain were obtained from a breeding colony maintained in the animal care facility at University of Missouri. The mice were 28-32 weeks old and on an average weighed 20-24g. The mice were fed a soy based-Purina 5001 lab chow (PMI feeds Inc., St. Louis, MO) which is reported to contain high levels of phytoestrogens. Recent studies suggest that dietary phytoestrogens may influence cardiovascular homeostasis (5, 12) . In the present study the observed effects of estrogen on baroreflex function may include contributions from phytoestrogens in the diet.
However, this contribution of dietary phytoestrogens to estrogenic activity should be comparable in all the three groups as all the mice were fed the same diet. All the protocols were approved by University of Missouri Animal Care and Use Committee.
The experimental groups consisted of: 1) Gonadally intact male mice (n=12), 2) Female mice, ovariectomized and implanted with silastic capsules containing 17ß-estradiol (E) in corn oil (OvxE+, n=7), 3) Female mice, ovariectomized and implanted with silastic capsules containing corn oil alone (OvxE-, n=6).
Surgical procedures
All the surgical procedures were carried out in mice anesthetized with a mixture of ketamine (100mg/kg IP) and xylazine (10mg/kg IP) and supplemented with isofluorane when necessary.
Ovariectomy and capsule implantation
Ten days before catheter implantation, the female mice were anesthetized and the ovaries were exposed via a dorsal midline incision. After rem ovi ng the ovar ies, a single silastic capsule containing either 17ß-estradiol (10 µg) or the vehicle corn oil was implanted subcutaneously and the incision was closed. For the purpose of making silastic capsules, a 14 mm length of silastic tubing (0.062" ID, 0.125" OD, Dow Corning) was filled with 20µl solution of estradiol dissolved in tocopherol stripped corn oil (0.5µg/µl).
Both ends were sealed with silastic adhesive (Konigsberg Instruments Inc.,), the final length of the tubing containing estradiol (E) or the vehicle being 10mm. The capsules were incubated in 0.9% NaCl overnight at room temperature before implanting in mice to provide a stable plasma estradiol concentration and to prevent a transitory peak in the plasma estrogen that would otherwise occur. Serum estradiol was measured by radioimmunoassay as described by vomSaal et al (48) . Radiolabeled estradiol and estradiol antibody were obtained from ICN (Costa Mesa, CA). Blood samples were collected at 14 days (n=3 in each group) after capsule implantation. Serum was separated by centrifugation and stored at -80 °C until the time of measurement. Samples from all the animals were run in duplicate in a single assay following extraction with ethyl acetate: chloroform (80:20, Fisher Scientific); the intraassay coefficient of variation was 4.2%, and assay sensitivity was 0.5 pg. In OvxE-mice serum concentrations were around 8.6± 0.6 pg/ ml. In OvxE+ mice the serum concentration of estradiol was 21±2 pg/ml.
Prior to ovariectomy, female mice weighed an average of 20±0.5g and the males weighed around 23±0.5g. Ten days after ovariectomy, the body weights of OvxE+ and OvxE-females were 24±0.5g and 25±0.8g respectively, indicating a comparable increase in body weight in ovariectomized females with (4.0 ± 0.1g) or without (4.5± 0.4g) estrogen replacement. The effectiveness of the estrogen replacement was also confirmed by comparing uterine weights of ovariectomized females with and without estrogen replacement. The uterus was collected from the mice after transecting from the oviduct at the utero-tubal junction bilaterally and at the junction of the uterine body and cervix. The entire uterus was wet weighed on a microbalance and the weight was expressed as mg/gm body weight to correct for differences in body weight. Uterine weight in ovariectomized mice with 17ß-estradiol replacement was 1.58±0.5 mg/gm and with corn oil replacement alone was 0.36±0.04 mg/gm. These uterine responses are within the physiological range of responses described previously in bioassays for estrogen implants (7).
Chronic catheterization
At least 4 days before the experiments, the mice were again anesthetized with ketamine/xylazine mixture and surgically instrumented with intra-arterial catheters for direct measurement of pulsatile and mean arterial pressure and heart rate (HR). Intravenous catheters were inserted for administration of drugs. Catheters made of microrenethane tubing (MRE25, Braintree Sci., Boston, MA) were inserted into the left femoral artery and right femoral vein. The catheters were then tunneled subcutaneously, exteriorized and placed in a plastic protective tube sutured in place at the back of the neck. The exterior catheters were heat sealed until use. The mice were housed individually in autoclaved filter top cages and allowed to recover from the surgery (3-4 days) before testing baroreflex function. In the interim, the catheters were flushed daily with dilute sterile heparinized saline (25 U/ml) to maintain patency and resealed. The mice were conscious and unrestrained in their own cages, while the exteriorized catheters were being connected to polyethylene tubing filled with heparinized saline for flushing.
For blood pressure recordings the arterial catheter was connected via polyethylene tubing filled with heparinized saline to a pressure transducer (MLT0698, AD instruments) placed at the level of the heart. Drugs were infused intravenously by a calibrated Razel pump modified for infusion of small volumes. The mice remained in individual home cages throughout the study and were handled only while replacing the bedding (twice/week). All the protocols were carried out between 0900 and 1500 hrs.
Experimental protocol
Resting mean arterial blood pressures and heart rates
Resting blood pressures and heart rates were measured in conscious, freely moving mice for a week. Within this week, baroreflex testing was in general carried out 3-4 days after surgery when the blood pressure readings were stable.
Evaluation of cardiac baroreflexes
On the day of the experiment, before any experimental intervention the mice were allowed to stabilize for at least 60 min following which a baseline recording of blood pressure was obtained. Arterial pressure was elevated with increasing doses of either intravenously administered phenylephrine (6ug/min) or AngII (0.6µg/min) for [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] second periods, and baroreflex curves were constructed relating mean arterial pressure (MAP) and heart rate (HR) (Figure 1 ). Infusion of the pressor agent was terminated immediately after a 30mmHg increase in blood pressure was achieved. After the blood pressure and heart rate returned to baseline, the venous catheter was flushed with a small volume of saline before attaching another line with a different pressor agent. The mice were allowed to recover for 45-60 minutes before subsequent drug administration taking care that the basal blood pressures and heart rates were within ±5% of the resting values.
Infusions of the pressor agents were in random order. Reflex tachycardic responses to decreases in blood pressure with sodium nitroprusside (SNP, 6.0µg/min) were measured at the end of the experiments.
A PowerLab® data acquisition system (AD instruments) with a sampling rate of 4000/s was used to record blood pressures and heart rates during the entire baroreflex function curve.
Data Analysis
Control values for arterial pressure and heart rate were taken as the 2-min average before the drug infusions. The data were represented as Mean ± SEM. Baroreflex function relating increases in arterial pressure with phenylephrine and AngII to decreases in HR was analyzed with linear regression analysis. Baroreflex function relating decreases in arterial pressure with SNP to increases in HR was analyzed with linear regression analysis. The reflex heart rate responses were compared using two-way analysis of variance. Newman-Keuls test was used to determine significance when indicated by analysis of variance. The slopes of baroreflex curves for phenylephrine and AngII within a group were compared with paired t-test and between groups were compared with unpaired t-test. The slopes of baroreflex curves for SNP between the groups were compared with an unpaired t-test. The probability level of p<0.05 was considered to be statistically significant.
Results
The basal values of arterial pressure and heart rate before evaluation of baroreflex function were comparable in the males (107±4 mmHg, 613±44 beats/min), OvxE+ (105±3, 644±36) and OvxE-(104±7, 663±40) females. The high basal heart rates could be an indication that mice are operating either at high sympathetic activity or low vagal activity (9, 21) . However, in the absence of direct measurements of peripheral sympathetic nerve activity it is difficult to determine the level of sympathetic activity in the mouse.
Baroreflex responses to phenylephrine (PE)
Baroreflex curves relating mean arterial pressure to inhibition of HR during intravenous infusions of PE in ovariectomized female mice with (OvxE+) and without (OvxE-) estrogen replacement are presented in figure 2 . In OvxE-, progressive increases in mean arterial pressure with phenylephrine resulted in a linearly related reflex decrease in HR, with a slope of -4.5±0.4 bpm/mmHg and regression coefficient of -0.95±0.02 (Table 1) . In OvxE+ mice, the reflex inhibition of HR in response to increases in arterial pressure with phenylephrine was greater than that observed in the OvxE-mice. This is reflected in a significantly greater slope of the baroreflex relation in OvxE+ female mice (-7.65±1.37 bpm/mmHg, r=-0.91±0.03, Table 1 , p=0.026). In intact male mice, progressive increases in mean arterial pressure with phenylephrine resulted in a linearly related reflex decrease in HR, with a slope of -8.50±0.92 bpm/mmHg (r=-0.88±0.02, Table 1 ).
Baroreflex responses to Angiotensin II (AngII)
Baroreflex curves relating mean arterial pressure to inhibition of HR during intravenous infusions of AngII in OvxE-and OvxE+ female mice are presented in figure   3 . In OvxE-, progressive increases in mean arterial pressure with AngII resulted in a linearly related reflex decrease in HR, with a slope of -4.8 ± 1.6 bpm/mmHg (r=-0.90±0.03, Table1). In OvxE+ mice, the reflex inhibition of HR in response to increases in arterial pressure with AngII was greater than that observed in the OvxE-mice. This is reflected in a significantly greater slope of the baroreflex relation in OvxE+ mice (- 
Baroreflex responses to AngII compared to PE
It is known that in many species acute AngII infusion results in blunted baroreflex gain and a resetting of the baroreceptor reflex control of HR to a higher pressure (1, 13, 31, 39) . The term "resetting" is generally used to describe a shift in the set point around which the baroreflexes operate. It may not always be accompanied by a change in the gain or slope of the baroreflex curve, which signifies a change in the reflex response to equivalent increases in arterial pressure. In the present study, we analyzed the gain of the baroreflex response to either PE or AngII. The differential baroreflex response to PE and AngII and the effect of estrogen has not been investigated in mice. In male mice, reflex inhibition of HR in response to increases in arterial pressure with AngII was significantly attenuated compared to the PE induced reflex inhibition of HR ( Figure 4A ).
A 30 mmHg increase in arterial pressure with PE infusion was accompanied by a 255 ± 40 bpm decrease in heart rate (slope: -8.50 ± 0.92 bpm/mmHg, Table 1 ). The same increase in arterial pressure with AngII infusion produced significantly smaller decreases in heart rate (148 ± 25 bpm, p=0.04), resulting in an attenuated reflex curve (slope: -5.17 ± 0.95 bpm/mmHg, p=0.008, Table1).
However, in OvxE+ female mice, the reflex inhibition of HR in responses to increases in arterial pressure with AngII were not different from that observed with PE (p=0.44, Figure 4B ). Similarly, in OvxE-female mice, though the reflex inhibition of HR was attenuated compared to OvxE+, there was no difference in the reflex response to increases in arterial pressure between PE and AngII (p=0.41, Figure 4C ).
Baroreflex responses to sodium nitroprusside (SNP)
Baroreflex curves relating decreases in mean arterial pressure to increases in HR during intravenous infusions of SNP in OvxE+, OvxE-and males are presented in figure   5 . In OvxE-, progressive decreases in mean arterial pressure with SNP resulted in a linearly related reflex increase in HR, with a slope of -1.1 ± 0.4 bpm/mmHg (r=-0.76 ± 0.09, Table1). Estrogen replacement in the ovariectomized females did not alter the baroreflex responses to SNP as indicated by the slope of the baroreflex relation in OvxE+ mice (-1.93 ± 0.47, r=-0.73±0.11, Table1). In males, the slope of the linear relation between decreases in mean arterial pressure and reflex increases in heart rate was -2.17±0.58 bpm/mmHg (r=-0.86±0.02, Table1) and was not significantly different compared to OvxE+ (p=0.39) or OvxE-(p=0.11).
Discussion
This study is the first to analyze the effects of estrogen and gender on cardiac baroreflex responses to phenylephrine, AngII and SNP in mice. The first finding was that in female mice, estrogen facilitated the baroreflex inhibition of HR induced by both phenylephrine and AngII.
The ability of estrogen to facilitate reflex regulation of heart rate and sympathetic activity is consistent with observations made in rats (10, 41, 43) blunted when compared to sham-operated rats and estrogen replacement reversed these effects (32) . It is possible that estrogen also acts at central autonomic regulatory nuclei in mice to facilitate PE induced changes in heart rate.
Phenylephrine induced reflex bradycardic responses in male mice were similar to OvxE+ females and significantly facilitated when compared to OvxE-females. In healthy normotensive humans, men in general have been shown to have higher cardiac baroreflex sensitivity to phenylephrine than age matched women, with baroreflex sensitivity being further depressed in older women (26, 35) . Estrogen replacement has been found to improve baroreflex function in women towards that seen in men (19) .
Intact male rats have also been shown to have greater PE induced baroreflex responses compared to intact females and this difference was significant when the rats were ovariectomized (10) . In this study estrogen replacement in the ovariectomized rats restored the cardiac baroreflex responses to a level similar to that observed in male rats.
Altogether, the data from the above studies and from the present study suggest that estrogen replacement normalizes the difference in PE induced cardiac baroreflex response.
The second finding of the present study is that there is a difference between males and females with regards to AngII mediated attenuation of reflex bradycardic responses in conscious mice. In dogs, rabbits and rats systemic administration of AngII has been demonstrated to increase BP without causing the large reflex bradycardia which normally accompanies such increases in BP suggesting that AngII resets the baroreflex control of HR to a higher pressure (29, 39) . It is widely accepted that this effect of AngII is due to central actions of this peptide on circumventricular organs such as area postrema (30, 34) .
In the present study, AngII mediated attenuation of reflex bradycardic responses was observed only in male mice. Reflex bradycardic responses to AngII compared to PE were not significantly different in females regardless of the status of estrogen replacement. The data may suggest that AngII induced effects on baroreflex control of HR are gender dependent. It is not clear if gender differences are observed in other species as most of the earlier studies in other species were performed in male animals or in induced ovulators such as female rabbits (3,17,30,31,38,39) . Reflex bradycardic responses to AngII have been examined in pregnant and non-pregnant ewes but definitive conclusions about gender differences cannot be made as the estrogen status of the females in these studies are unknown and due to lack of systematic comparisons to males (20, 27) . Reflex increases in pulse interval to AngII mediated increases in blood pressure were blunted compared to PE in both the pregnant and the non-pregnant ewes.
However, in contrast to the present study, this blunting was in general observed at pressure increases greater than 30 mmHg (20) . In a second study, AngII mediated increases in blood pressure in non-pregnant ewes when counteracted with sodium nitroprusside infusion resulted in tachycardia. However in this study, the responses in the non-pregnant females were grouped together with castrated males (27) .
There is some evidence in humans that suggests gender related differences in AngII mediated effects on cardiac baroreflexes (14) . In a recent study comparing premenopausal women and age-matched men, AngII infusion produced similar increases in blood pressures. However in men, reflex decreases in heart rate were blunted relative to those observed in women. These findings are similar to that observed in the present study in mice and suggest that mice may prove to be a reasonable model for understanding gender differences in baroreflex and cardiovascular function in humans.
However, it should be noted that the gender comparisons in the present study were made between intact males and ovariectomized females with or without estrogen replacement.
Other gonadal hormones such as progesterone and testosterone are also known to effect baroreflex function and cardiovascular homeostasis (6, 8, 11) . The observations made with regards to gender differences in this study are limited to the contribution of estrogen alone. The 4-day long estrous cycle in intact female rodents is accompanied by significant variations in estrogen and progesterone levels (15, 47, 51) . A complete analysis of gender differences would require evaluation of baroreflex responses in intact females with known serum levels of endogenous ovarian hormones and in males with known levels of testosterone.
The molecular and cellular mechanisms underlying gender differences in AngII modulation of baroreflex are unknown, however, it has been shown that in ovariectomized rats estrogen replacement decreases AT 1 receptor expression and binding affinity at several central sites including the subfornical organ (SFO), a circumventricular organ (24, 25, 40, 44) . In mice, it is interesting to hypothesize that AngII receptor (AT 1 ) expression at central nucleii mediating the effects of AngII on baroreflex function could be greater in males compared to OvxE+ females. Additional biochemical and molecular studies are planned to test this hypothesis.
Increases in AT 1 receptor expression associated with decreases in estrogen levels may also account for the significantly smaller reflex bradycardic responses to AngII in the OvxE-females. However, unlike the males, reflex bradycardic responses to phenylephrine are also significantly blunted in the OvxE-. It is possible that in female mice, estrogen modulates reflex bradycardic responses to phenylephrine and AngII via different mechanisms. It is well documented that the one site of central action of angiotensin II is the area postrema which has neuronal projections to the nucleus tractus solitarius and the dorsal vagal complex and consequently is able to modulate activity in baroreceptor afferents in the hindbrain (22, 33) . Angiotensin II has been shown to activate the area postrema neurons and lesioning of this region abolishes AngII mediated attenuation of reflex bradycardic responses in male rats and rabbits (2, 13, 30) . In rats, spontaneous area postrema neuronal activity is inhibited by intravenous infusion of 17ß-estradiol probably by potentiating voltage gated potassium currents (28) . This effect on area postrema neuronal activity was rapid in onset suggesting a non-genomic mechanism.
It is possible, estrogen replacement in the OvxE+ mice may alter the membrane properties of the area postrema neurons and attenuate AngII mediated increases in area postrema neuronal activity.
Activation of sympathetic outflow and reduction in parasympathetic outflow at least to the heart in response to decreases in arterial pressure with SNP, did not appear to be influenced by gender or the levels of circulating estrogen in the mice. A definitive conclusion with regards to differences in reflex regulation of sympathetic tone in these mice cannot be ruled out in the absence of direct measurement of sympathetic nerve activity (SNA).
Perspectives
This is the first study to report cardiac baroreflex function and the role of estrogen in a conscious mouse model. Similar to observations made in other species, it is evident that estrogen has significant effects on cardiovascular regulation in the mouse. With the availability of several estrogen receptor knockout models, studies in the mouse species allow for further elucidation of mechanisms underlying the regulatory effects of estrogen on cardiovascular function. Delineation of the receptor subtype involved in mediating the beneficial cardiovascular effects could be useful in designing effective therapies to treat and/ or prevent cardiovascular disease in women. 
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